Literature DB >> 2551940

A case of tubular apocrine adenoma with syringocystadenoma papilliferum.

S Ansai1, S Watanabe, K Aso.   

Abstract

We report a new case of a Japanese man who developed a tubular apocrine adenoma in association with syringocystadenoma papilliferum. The differences in the histopathological and immunohistochemical findings in these 2 tumors are described. This is the first immunohistochemical study of tubular apocrine adenoma.

Entities:  

Mesh：

Year:  1989        PMID： 2551940     DOI： 10.1111/j.1600-0560.1989.tb00047.x

Source DB:  PubMed          Journal:  J Cutan Pathol        ISSN： 0303-6987            Impact factor:   1.587


  6 in total

1.  Syringocystadenoma Papilliferum in Co-existence with Tubular Apocrine Adenoma on the Calf.

Authors:  Jung Hee Yoon; Hyo Hyun Ahn; Young Chul Kye; Soo Hong Seo
Journal:  Ann Dermatol       Date:  2011-10-31       Impact factor: 1.444

2.  Syringocystadenoma papilliferum of the back combined with a tubular apocrine adenoma.

Authors:  Hyun Joo Lee; Eujin Cho; Min Ho Kim; Sang Hyun Cho; Jeong Deuk Lee
Journal:  Ann Dermatol       Date:  2011-10-31       Impact factor: 1.444

3.  A proliferating composite adnexal tumour of the penis: report of the first case.

Authors:  Nidal A Obaidat; Danny M Ghazarian
Journal:  J Clin Pathol       Date:  2007-05       Impact factor: 3.411

Review 4.  Skin adnexal neoplasms--part 2: an approach to tumours of cutaneous sweat glands.

Authors:  Nidal A Obaidat; Khaled O Alsaad; Danny Ghazarian
Journal:  J Clin Pathol       Date:  2006-08-01       Impact factor: 3.411

5.  A Case of Tubular Apocrine Adenoma with Syringocystadenoma Papilliferum that Developed in a Nevus Sebaceus.

Authors:  Mi Sun Kim; June Hyunkyung Lee; Won-Mi Lee; Sook-Ja Son
Journal:  Ann Dermatol       Date:  2010-08-05       Impact factor: 1.444

6.  Combined melanocytic and sweat gland neoplasm: cell subsets harbor an identical HRAS mutation in phacomatosis pigmentokeratotica.

Authors:  Janet Y Li; Michael F Berger; Ashfaq Marghoob; Umesh K Bhanot; Jennifer P Toyohara; Melissa P Pulitzer
Journal:  J Cutan Pathol       Date:  2014-07-09       Impact factor: 1.587
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.